Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Numerion Labs has raised $19.8M in total funding. The most recent round was Series D. The last funding was announced in March 2026.
Numerion Labs's investors include B Capital, Bill & Melinda Gates Foundation, Draper Associates, Khosla Ventures, Y Combinator.
Numerion Labs is headquartered in San Francisco, United States.
Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Numerion Labs is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Numerion Labs — Funding & Investors." VCBacked, March 19, 2026, https://www.vcbacked.co/company/numerion-labs. Accessed September 2, 2026.
VCBacked. (2026). Numerion Labs — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/numerion-labs
{{cite web |title=Numerion Labs — Funding & Investors |url=https://www.vcbacked.co/company/numerion-labs |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated